Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ONABOTULINUMTOXINA Cause Migraine? 1,232 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 1,232 reports of Migraine have been filed in association with ONABOTULINUMTOXINA. This represents 2.5% of all adverse event reports for ONABOTULINUMTOXINA.

1,232
Reports of Migraine with ONABOTULINUMTOXINA
2.5%
of all ONABOTULINUMTOXINA reports
24
Deaths
172
Hospitalizations

How Dangerous Is Migraine From ONABOTULINUMTOXINA?

Of the 1,232 reports, 24 (1.9%) resulted in death, 172 (14.0%) required hospitalization, and 29 (2.4%) were considered life-threatening.

Is Migraine Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ONABOTULINUMTOXINA. However, 1,232 reports have been filed with the FAERS database.

What Other Side Effects Does ONABOTULINUMTOXINA Cause?

Drug ineffective (18,179) Off label use (9,698) Product preparation error (3,593) Multiple use of single-use product (2,781) Therapeutic response decreased (2,685) Headache (2,316) Injection site pain (2,143) Eyelid ptosis (1,853) Wrong technique in product usage process (1,477) Death (1,153)

What Other Drugs Cause Migraine?

ERENUMAB-AOOE (4,290) ADALIMUMAB (4,238) GALCANEZUMAB-GNLM (2,612) METHOTREXATE (2,532) ETANERCEPT (2,320) PREDNISONE (2,203) APREMILAST (2,154) INFLIXIMAB (2,137) RITUXIMAB (1,894) TOFACITINIB (1,878)

Which ONABOTULINUMTOXINA Alternatives Have Lower Migraine Risk?

ONABOTULINUMTOXINA vs ONASEMNOGENE ABEPARVOVEC ONABOTULINUMTOXINA vs ONASEMNOGENE ABEPARVOVEC-XIOI ONABOTULINUMTOXINA vs ONBREZ ONABOTULINUMTOXINA vs ONDANSETRON ONABOTULINUMTOXINA vs ONFI

Related Pages

ONABOTULINUMTOXINA Full Profile All Migraine Reports All Drugs Causing Migraine ONABOTULINUMTOXINA Demographics